Artificial respiration

From Citizendium
Revision as of 13:47, 14 July 2008 by imported>Robert Badgett (→‎Inconsistent terminology)
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, artificial respiration is "Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have respiratory insufficiency to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2)."[1]

Classification

Using intratracheal intubation

  • PEEP

Noninvasive

According to the U.S. National Library of Medicine, the terms for the types of nonvinvasive ventilation are:

Inconsistent terminology of noninvasive modes

The terminology for noninvasive respiratory support is inconsistently used in the medical literature.

  • Some authors interchange IPPB with IPPV. B indicates the patient is spontaneously breathing while V indicates ventilation via intratracheal intubation.
  • Some authors interchange IPPB and IPPV with bilevel PAP as done in a recent randomized controlled trial.[2]
  • Some authors interchange bilevel PAP with BiPAP. The latter is a specific brand of a bilevel PAP ventilator.

Effectiveness

Chronic obstructive pulmonary disease

All types of noninvasive ventilation studied through 2003 may help respiratory insufficiency due to chronic obstructive pulmonary disease[3], especially if the exacerbations are severe[4].

Heart failure

Noninvasive ventilation may help treat respiratory insufficiency due to heart failure, but the optimal mode of noninvasive ventilation is not clear. A systematic review found that CPAP may be better than bilevel PAP.[5] However, in a more recent randomized controlled trial of respiratory insufficiency due to heart failure, neither CPAP or bilevel PAP reduced mortality as compared to standard oxygen therapy; however, both of the noninvasive methods provided similar symptomatic and metabolic improvement.[2] In this trial CPAP was started at 5 cm of water and increased as needed to 15 cm of water. Bilevel PAP was started at an inspiratory positive airway pressure of 8 cm of water and an expiratory positive airway pressure of 4 cm of water and was increased as needed to an inspiratory pressure of 20 cm of water and expiratory pressure of 10 cm of water.[2]

References